$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000155837023008830 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$4.126M	$4.137M
YoY Change	11.09%	66.75%
Cost Of Revenue	$3.709M	$3.723M
YoY Change	28.34%	90.53%
Gross Profit	$400.0K	$400.0K
YoY Change	-51.46%	-24.1%
Gross Profit Margin	9.69%	9.67%
Selling, General & Admin	$7.455M	$7.718M
YoY Change	-12.92%	-2.09%
% of Gross Profit	1863.75%	1929.5%
Research & Development	$12.83M	$12.41M
YoY Change	37.97%	58.96%
% of Gross Profit	3207.5%	3101.25%
Depreciation & Amortization	$218.0K	$236.0K
YoY Change	-15.18%	-10.27%
% of Gross Profit	54.5%	59.0%
Operating Expenses	$20.29M	$20.12M
YoY Change	13.58%	28.28%
Operating Profit	-$19.87M	-$19.71M
YoY Change	16.62%	30.01%
Interest Expense	$2.310M	$4.652M
YoY Change	-98.08%	3.52%
% of Operating Profit
Other Income/Expense, Net	-$555.0K	$21.03M
YoY Change	967.31%	-79.35%
Pretax Income	-$20.42M	$1.324M
YoY Change	-119.59%	-98.47%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$20.42M	$1.324M
YoY Change	-119.59%	-98.47%
Net Earnings / Revenue	-494.98%	32.0%
Basic Earnings Per Share	-$0.04	$0.00
Diluted Earnings Per Share	-$0.04	$0.00
COMMON SHARES
Basic Shares Outstanding	479.9M	479.8M
Diluted Shares Outstanding	567.1M	540.5M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$125.1M	$136.6M
YoY Change	-10.14%	-18.16%
Cash & Equivalents	$28.55M	$45.09M
Short-Term Investments	$96.52M	$91.52M
Other Short-Term Assets	$5.708M	$6.163M
YoY Change	-23.88%	-15.47%
Inventory	$9.194M	$8.195M
Prepaid Expenses
Receivables	$3.675M	$3.404M
Other Receivables	$2.034M	$130.0K
Total Short-Term Assets	$138.2M	$146.3M
YoY Change	-12.68%	-8.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$925.0K	$1.042M
YoY Change	-26.76%	-21.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.453M	$8.157M
YoY Change	-34.24%	-67.56%
Other Assets	$1.415M	$2.998M
YoY Change	-68.07%	184.17%
Total Long-Term Assets	$15.13M	$12.20M
YoY Change	-11.13%	-55.68%
TOTAL ASSETS
Total Short-Term Assets	$138.2M	$146.3M
Total Long-Term Assets	$15.13M	$12.20M
Total Assets	$153.4M	$158.5M
YoY Change	-12.53%	-15.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$975.0K	$646.0K
YoY Change	-43.77%	-69.08%
Accrued Expenses	$14.89M	$13.56M
YoY Change	3.32%	10.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$15.86M	$14.28M
YoY Change	-49.6%	-54.65%
LONG-TERM LIABILITIES
Long-Term Debt	$39.11M	$37.48M
YoY Change	-22.79%	-21.98%
Other Long-Term Liabilities	$6.408M	$2.576M
YoY Change	-91.71%	664.39%
Total Long-Term Liabilities	$6.408M	$2.576M
YoY Change	-94.99%	664.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.86M	$14.28M
Total Long-Term Liabilities	$6.408M	$2.576M
Total Liabilities	$63.17M	$56.41M
YoY Change	-60.37%	-79.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$828.0M	-$807.5M
YoY Change		-6.57%
Common Stock	$493.0K	$480.0K
YoY Change		3.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.54M	$64.46M
YoY Change
Total Liabilities & Shareholders Equity	$153.4M	$158.5M
YoY Change	-12.53%	-15.72%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$20.42M	$1.324M
YoY Change	-119.59%	-98.47%
Depreciation, Depletion And Amortization	$218.0K	$236.0K
YoY Change	-15.18%	-10.27%
Cash From Operating Activities	-$17.98M	-$19.85M
YoY Change	26.81%	-1.54%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$57.00K
YoY Change	-100.0%	-141.61%
Acquisitions
YoY Change
Other Investing Activities	-$4.076M	$30.00M
YoY Change	-118.1%	51.51%
Cash From Investing Activities	-$4.076M	$29.95M
YoY Change	-118.16%	52.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.526M	-807.0K
YoY Change	-399.35%	-113.35%
NET CHANGE
Cash From Operating Activities	-17.98M	-19.85M
Cash From Investing Activities	-4.076M	29.95M
Cash From Financing Activities	5.526M	-807.0K
Net Change In Cash	-16.53M	9.292M
YoY Change	-357.78%	67.42%
FREE CASH FLOW
Cash From Operating Activities	-$17.98M	-$19.85M
Capital Expenditures	$0.00	$57.00K
Free Cash Flow	-$17.98M	-$19.91M
YoY Change	27.47%	-0.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	479637138
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	479780414
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230331#DepositsAndOtherAssetsNoncurrent
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230331#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230331#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37717
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Senseonics Holdings, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
CY2023Q1	dei	City Area Code CityAreaCode	301
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	515-7260
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	SENS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	479871695
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45085000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35793000
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	83359000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	108222000
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	451000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	127000
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2953000
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2324000
CY2023Q1	us-gaap	Inventory Net InventoryNet	8195000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6293000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	146336000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	161200000
CY2023Q1	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	2998000
CY2022Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3108000
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	8157000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	12253000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1042000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1112000
CY2023Q1	us-gaap	Assets Assets	158533000
CY2022Q4	us-gaap	Assets Assets	177673000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	646000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	419000
CY2023Q1	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	12808000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	14616000
CY2023Q1	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	823000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	837000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	15579000
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	20000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14277000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31471000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	37479000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	56383000
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2081000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	52050000
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2576000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2689000
CY2023Q1	us-gaap	Liabilities Liabilities	56413000
CY2022Q4	us-gaap	Liabilities Liabilities	142593000
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2023Q1	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	479780414
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	479637138
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	480000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	480000
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	871746000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	806488000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-220000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-678000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-807542000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-808866000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	64464000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	158533000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	177673000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	292000
CY2023Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3824000
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2189000
CY2023Q1	us-gaap	Revenues Revenues	4137000
CY2022Q1	us-gaap	Revenues Revenues	2481000
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3723000
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1954000
CY2023Q1	us-gaap	Gross Profit GrossProfit	414000
CY2022Q1	us-gaap	Gross Profit GrossProfit	527000
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12405000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7804000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7718000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7883000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19709000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15160000
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1108000
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	93000
CY2022Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	21701000
CY2023Q1	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
CY2023Q1	us-gaap	Interest Expense InterestExpense	4652000
CY2022Q1	us-gaap	Interest Expense InterestExpense	4494000
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	5778000
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	84569000
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-30000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21033000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101878000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	458000
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-625000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	458000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-625000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1782000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	86093000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497473222
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	455942886
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	540532813
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605198839
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8004000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	171000
CY2022Q1	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	62000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1736000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-625000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-89469000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-65000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	63542000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1781000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	458000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	64464000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1324000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	86718000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	236000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	263000
CY2023Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	2625000
CY2022Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	2772000
CY2023Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-5778000
CY2022Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-84569000
CY2022Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	21701000
CY2023Q1	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
CY2022Q1	sens	Impairment Of Options ImpairmentOfOptions	30000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1781000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1736000
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	-15000
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	56000
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	953000
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2056000
CY2023Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-1136000
CY2022Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	1411000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	874000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	837000
CY2022Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-163000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	227000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	886000
CY2023Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-267000
CY2022Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-2031000
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-315000
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-62000
CY2023Q1	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-255000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19848000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20159000
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	57000
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	137000
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	9653000
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	39657000
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	19803000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29947000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19666000
CY2022Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	8004000
CY2023Q1	sens	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	-65000
CY2022Q1	sens	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	233000
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15700000
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14958000
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2194000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-807000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6043000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9292000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5550000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35793000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33461000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45085000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39011000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1756000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1762000
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	48000
CY2023Q1	sens	Issuance Of Warrant In Exchange For Phc Notes IssuanceOfWarrantInExchangeForPhcNotes	48550000
CY2022	us-gaap	Gross Profit GrossProfit	2700000
CY2021	us-gaap	Gross Profit GrossProfit	-800000
CY2020	us-gaap	Gross Profit GrossProfit	-17400000
CY2023Q1	us-gaap	Gross Profit GrossProfit	400000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-807500000
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	136600000
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	15000000.0
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, fair value of investments, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, bad debts, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
CY2023Q1	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2023Q1	us-gaap	Revenues Revenues	4137000
CY2023Q1	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2022Q1	us-gaap	Revenues Revenues	2481000
CY2022Q1	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1500000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1700000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	86718000
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	-2293000
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	-104575000
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-969000
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-17857000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497473222
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	455942886
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2905016
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8982055
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	943217
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5685919
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	540532813
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605198839
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47283899
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35015905
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91736000
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	220000
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	91516000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121153000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	678000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	120475000
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	76629000
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	76471000
CY2023Q1	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearTwo	8364000
CY2023Q1	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	8361000
CY2023Q1	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearThree	6743000
CY2023Q1	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree	6684000
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91736000
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	91516000
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2595000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1697000
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4074000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4057000
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1526000
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1552000
CY2023Q1	us-gaap	Inventory Net InventoryNet	8195000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4699000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2023Q1	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	3868000
CY2022Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	4097000
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	983000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1243000
CY2023Q1	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	695000
CY2022Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	924000
CY2023Q1	sens	Research And Development ResearchAndDevelopment	251000
CY2022Q4	sens	Research And Development ResearchAndDevelopment	67000
CY2023Q1	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	133000
CY2022Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	189000
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	130000
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	336000
CY2023Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	113000
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	158000
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	106000
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	132000
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	14000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	12000
CY2022Q4	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	270000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6293000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2023Q1	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3000000.0
CY2022Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3100000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2900000
CY2023Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	33000
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	4926000
CY2022Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	3502000
CY2023Q1	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	2643000
CY2022Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	2480000
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2162000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1053000
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1521000
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	772000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	781000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	661000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	725000
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	560000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2050000
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	315000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	149000
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	71000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14000
CY2023Q1	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	13631000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	15453000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2600000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2700000
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	700000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	700000
CY2023Q1	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	800000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	800000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
CY2022	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	166000
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	9000
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	108000
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	772000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1441000
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3097000
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	114000
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4652000
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1700000
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2683000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	87000
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4470000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	51199000
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	51199000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0

Files In Submission

Name	View Source	Status
0001558370-23-008830-index-headers.html	Edgar Link	pending
0001558370-23-008830-index.html	Edgar Link	pending
0001558370-23-008830.txt	Edgar Link	pending
0001558370-23-008830-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20230331.xsd	Edgar Link	pending
sens-20230331x10q.htm	Edgar Link	pending
sens-20230331xex10d1.htm	Edgar Link	pending
sens-20230331xex10d2.htm	Edgar Link	pending
sens-20230331xex31d1.htm	Edgar Link	pending
sens-20230331xex31d2.htm	Edgar Link	pending
sens-20230331xex32d1.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sens-20230331_cal.xml	Edgar Link	unprocessable
sens-20230331_def.xml	Edgar Link	unprocessable
sens-20230331_pre.xml	Edgar Link	unprocessable
sens-20230331_lab.xml	Edgar Link	unprocessable
sens-20230331x10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2023 Q2 Form 10-Q Financial Statement

#000155837023008830 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2023 Q2 Form 10-Q Financial Statement

#000155837023008830 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens